The generality of these processes raises the possibility that a wider range of cell types (i.e., metastatic cancer cells, other embryonic cells) undergoing similar qualitative changes of their cadherin repertoire might acquire CIL as part of their progression through EMT, contributing to disease progression or developmental morphogenesis. This evidence concerns the gene CDH17 and cancer.